Yahoo Web Search

Search results

  1. 1 day ago · A study found that treatment with HEPZATO KIT showed a promising response rate of 36.3% for patients with unresectable metastatic uveal melanoma. NEWS All News FDA Briefs Oncology Icons Special Reports Voices from the Field

  2. 3 days ago · Uveal melanoma originates in the uveal tract of the eye but has a tendency to aggressively spread throughout the body, often to the liver. When metastasis occurs, this cancer is very difficult to treat and the prognosis for patients is almost always grim.

  3. 3 days ago · Uveal melanoma is an aggressive cancer of the eye, and despite high primary tumor cure rates, metastatic disease spread eventually impacts about half of all patients. 1 The DecisionDx-UM test is considered the standard of care in the management of newly diagnosed UM to assist in determining risk of metastasis, which is critical for informing ...

  4. 2 days ago · Ocular melanoma is uncommon and has two types. Hensley’s case was uveal melanoma, which are tumors that are found inside of the eye. This type of melanoma is very rare with only 2,500 cases per year in the United States, which equals about five patients per million.

  5. 3 days ago · Uveal melanoma is a rare and aggressive intraocular malignant cancer with a propensity for fatal liver metastasis in up to 50% of patients. 1 Activity of the Brahma‐related gene (BRG)/Brahma-associated factor (BAF) chromatin remodeling complex is essential for uveal melanoma cell proliferation, and inhibiting the BAF ATPase subunits BRG1 and BRM has shown promise as a novel treatment in ...

  6. 3 days ago · Stereotactic radiosurgery (SRS) is a well-established treatment modality for the management of uveal melanoma, achieving high tumor control and eye retention rates. There are several SRS treatment platforms available, including the recently developed self-shielding gyroscopic radiosurgery (GRS) system. We report the first use of GRS in the treatment of uveal melanoma. We report the treatment ...

  7. 3 days ago · Josep Maria Piulats Rodriguez, MD, PhD, chair, Uveal Melanoma, the Spanish Melanoma Group, medical oncologist, Institut Català d’Oncologia–Bellvitge Institute for Biomedical Research ...

  1. People also search for